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Introduction
Methods
• Latinx are 18% of the US population. Significant health 
disparities in depression treatment and medication adherence 
exist between US Latinx and US Whites.
• Latinx individuals with depression receive antidepressant 
treatment 1/3 as often as Whites with depression. 
• Depression is a leading cause of disability. Latinxs are half as 
likely to seek treatment for depression, but when they do, 
they 2x as likely to seek help in a primary care setting rather 
than specialty mental health care than Whites.
• Over 40% of Latinx discontinue antidepressant therapy within 
30 days and less than 30% continue for more than 90 days. 
• Culture is defined as integrated pattern of thoughts, language, 
customs, beliefs, values, and institutions associated with 
ethnic groups, as well as religious, spiritual, biological, 
geographical, or sociological characteristics1,2
• Cultural factors could explain some intentional nonadherence 
to Ads
• Community based participatory research in Ypsilanti and
Detroit could offer insight and be a site for a uniquely tailored 
intervention
Workflow analysis
Flow of workers, patients, and information 
across space and time at clinics and onsite 
pharmacies conducted by PI. 
Systematic Review/Meta-Analysis
Conduct SR/MA to assess role of culture on medication 
adherence to antidepressants among Latinx with depression.
Putting together the components of the intervention
Investigators will compile messaging and develop motivational interviewing scripts, personnel training, resources 
to address barriers to nonadherence, educational materials, and other components as needed.
Focus group and interview feedback to develop/refine intervention components
Conduct separate focus groups with bilingual physicians and other care professionals from each clinic and 
conduct interviews with pharmacists to develop intervention for each site and respective Latinx populations.  
Steering Committee to refine and approve intervention
Steering Committee will refine intervention for each site and respective Latinx populations. Steering Committee will give its 





Future Directions and 
Pending Results
Results
1. Finish coding the data from 
our focus groups in CHASS 
and Ypsilanti
2. Develop the intervention 
with the input and clearance 
of our Steering Committee
3. Perform focus groups aimed 
at assessing efficacy of 
intervention/adjusting to 
participant response.
